The Productivity Paradox: Can AI Fix Pharma’s R&D Crisis?
Jan 22, 2025•37 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Despite a $145.5 billion investment in pharmaceutical R&D in 2023, US Federal Drug Administration novel drug approvals remain stagnant at around 43 annually, according to recent findings from Deloitte’s 14th Annual Pharmaceutical Innovation Report. The complexity of modern diseases, combined
For the best experience, listen in Metacast app for iOS or Android